Dyne Therapeutics Inc. (DYN) is priced at $19.45 after the most recent trading session. At the very opening of the session, the stock price was $18.41 and reached a high price of $18.98, prior to closing the session it reached the value of $18.62. The stock touched a low price of $18.15.
Recently in News on February 8, 2021, Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs. Dr. Dugar Brings Over 20 Years of Experience in Medical Affairs, Clinical and Commercial Development, and Real-World Evidence, Including in Rare Muscle Disease. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Dyne Therapeutics Inc. shares are logging -39.81% during the 52-week period from high price, and 24.68% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $15.60 and $32.31.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 447218 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Dyne Therapeutics Inc. (DYN) recorded performance in the market was -11.33%, having the revenues showcasing -3.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 968.24M, as it employees total of 36 workers.
The Analysts eye on Dyne Therapeutics Inc. (DYN)
During the last month, 0 analysts gave the Dyne Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 20.48, with a change in the price was noted -3.92. In a similar fashion, Dyne Therapeutics Inc. posted a movement of -17.77% for the period of last 100 days, recording 371,192 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for DYN is recording 0.03 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.03.
Technical rundown of Dyne Therapeutics Inc. (DYN)
Raw Stochastic average of Dyne Therapeutics Inc. in the period of last 50 days is set at 4.32%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 6.90%. In the last 20 days, the company’s Stochastic %K was 7.03% and its Stochastic %D was recorded 7.15%.
Considering, the past performance of Dyne Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -11.33%. The shares increased approximately by -4.46% in the 7-day charts and went up by -34.92% in the period of the last 30 days. Common stock shares were lifted by -3.57% during last recorded quarter.